Buprenorphine/naloxone, like methadone, continues to be shown in medical trials being efficient in managing heroin dependence, and could possibly have a reduced hazard for withdrawal outcomes upon discontinuation. Naloxone (a pure opiate antagonist at receptor websites) is current to help avoid the intravenous abuse of the buprenorphine component.